The global Endoscope + Radiofrequency Ablation (RFA) market size was valued at USD 3678.7 million in 2023 and is forecast to a readjusted size of USD 5234.5 million by 2030 with a CAGR of 5.2% during review period.
Radiofrequency ablation (RFA) is one of the most promising ablative techniques for BE. The technique uses a bipolar electrode that is available as a balloon-based device for primary circumferential ablation or as a cap-based device that can be mounted on the tip of the endoscope for focal ablation.
The key factors that boost the growth of the global endoscope + radiofrequency ablation (RFA) market include upsurge in demand for novel treatment methods for patients suffering from cancer, cardiovascular diseases, and disorders associated with chronic pain along with the benefits offered by this advanced treatment modality. Several research studies have concluded that radiofrequency ablation (RFA) treatment efficiently creates lesion in the targeted body parts while maintaining short procedure durations.
This report includes an overview of the development of the Endoscope + Radiofrequency Ablation (RFA) industry chain, the market status of Cardiology Application (Focal Ablation, Others), Pain Management (Focal Ablation, Others), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Endoscope + Radiofrequency Ablation (RFA).
Regionally, the report analyzes the Endoscope + Radiofrequency Ablation (RFA) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Endoscope + Radiofrequency Ablation (RFA) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Endoscope + Radiofrequency Ablation (RFA) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Endoscope + Radiofrequency Ablation (RFA) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Focal Ablation, Others).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Endoscope + Radiofrequency Ablation (RFA) market.
Regional Analysis: The report involves examining the Endoscope + Radiofrequency Ablation (RFA) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Endoscope + Radiofrequency Ablation (RFA) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Endoscope + Radiofrequency Ablation (RFA):
Company Analysis: Report covers individual Endoscope + Radiofrequency Ablation (RFA) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Endoscope + Radiofrequency Ablation (RFA) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cardiology Application, Pain Management).
Technology Analysis: Report covers specific technologies relevant to Endoscope + Radiofrequency Ablation (RFA). It assesses the current state, advancements, and potential future developments in Endoscope + Radiofrequency Ablation (RFA) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Endoscope + Radiofrequency Ablation (RFA) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Endoscope + Radiofrequency Ablation (RFA) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Focal Ablation
Others
Market segment by Application
Cardiology Application
Pain Management
Oncology Application
Other Application
Market segment by players, this report covers
Boston Scientific Corporation Conmed Corporation
Medtronic Plc (Covidien Plc)
Smith and Nephew Plc
Stryker Corporation
Halyard Health
Abbott Laboratories (St. Jude Medical, Inc.)
AngioDynamics
Hologic
AtriCure
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Endoscope + Radiofrequency Ablation (RFA) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Endoscope + Radiofrequency Ablation (RFA), with revenue, gross margin and global market share of Endoscope + Radiofrequency Ablation (RFA) from 2019 to 2024.
Chapter 3, the Endoscope + Radiofrequency Ablation (RFA) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Endoscope + Radiofrequency Ablation (RFA) market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Endoscope + Radiofrequency Ablation (RFA).
Chapter 13, to describe Endoscope + Radiofrequency Ablation (RFA) research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Endoscope + Radiofrequency Ablation (RFA)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Endoscope + Radiofrequency Ablation (RFA) by Type
1.3.1 Overview: Global Endoscope + Radiofrequency Ablation (RFA) Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Endoscope + Radiofrequency Ablation (RFA) Consumption Value Market Share by Type in 2023
1.3.3 Focal Ablation
1.3.4 Others
1.4 Global Endoscope + Radiofrequency Ablation (RFA) Market by Application
1.4.1 Overview: Global Endoscope + Radiofrequency Ablation (RFA) Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cardiology Application
1.4.3 Pain Management
1.4.4 Oncology Application
1.4.5 Other Application
1.5 Global Endoscope + Radiofrequency Ablation (RFA) Market Size & Forecast
1.6 Global Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast by Region
1.6.1 Global Endoscope + Radiofrequency Ablation (RFA) Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Endoscope + Radiofrequency Ablation (RFA) Market Size by Region, (2019-2030)
1.6.3 North America Endoscope + Radiofrequency Ablation (RFA) Market Size and Prospect (2019-2030)
1.6.4 Europe Endoscope + Radiofrequency Ablation (RFA) Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Market Size and Prospect (2019-2030)
1.6.6 South America Endoscope + Radiofrequency Ablation (RFA) Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Endoscope + Radiofrequency Ablation (RFA) Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Boston Scientific Corporation Conmed Corporation
2.1.1 Boston Scientific Corporation Conmed Corporation Details
2.1.2 Boston Scientific Corporation Conmed Corporation Major Business
2.1.3 Boston Scientific Corporation Conmed Corporation Endoscope + Radiofrequency Ablation (RFA) Product and Solutions
2.1.4 Boston Scientific Corporation Conmed Corporation Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Boston Scientific Corporation Conmed Corporation Recent Developments and Future Plans
2.2 Medtronic Plc (Covidien Plc)
2.2.1 Medtronic Plc (Covidien Plc) Details
2.2.2 Medtronic Plc (Covidien Plc) Major Business
2.2.3 Medtronic Plc (Covidien Plc) Endoscope + Radiofrequency Ablation (RFA) Product and Solutions
2.2.4 Medtronic Plc (Covidien Plc) Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Medtronic Plc (Covidien Plc) Recent Developments and Future Plans
2.3 Smith and Nephew Plc
2.3.1 Smith and Nephew Plc Details
2.3.2 Smith and Nephew Plc Major Business
2.3.3 Smith and Nephew Plc Endoscope + Radiofrequency Ablation (RFA) Product and Solutions
2.3.4 Smith and Nephew Plc Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Smith and Nephew Plc Recent Developments and Future Plans
2.4 Stryker Corporation
2.4.1 Stryker Corporation Details
2.4.2 Stryker Corporation Major Business
2.4.3 Stryker Corporation Endoscope + Radiofrequency Ablation (RFA) Product and Solutions
2.4.4 Stryker Corporation Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Stryker Corporation Recent Developments and Future Plans
2.5 Halyard Health
2.5.1 Halyard Health Details
2.5.2 Halyard Health Major Business
2.5.3 Halyard Health Endoscope + Radiofrequency Ablation (RFA) Product and Solutions
2.5.4 Halyard Health Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Halyard Health Recent Developments and Future Plans
2.6 Abbott Laboratories (St. Jude Medical, Inc.)
2.6.1 Abbott Laboratories (St. Jude Medical, Inc.) Details
2.6.2 Abbott Laboratories (St. Jude Medical, Inc.) Major Business
2.6.3 Abbott Laboratories (St. Jude Medical, Inc.) Endoscope + Radiofrequency Ablation (RFA) Product and Solutions
2.6.4 Abbott Laboratories (St. Jude Medical, Inc.) Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Abbott Laboratories (St. Jude Medical, Inc.) Recent Developments and Future Plans
2.7 AngioDynamics
2.7.1 AngioDynamics Details
2.7.2 AngioDynamics Major Business
2.7.3 AngioDynamics Endoscope + Radiofrequency Ablation (RFA) Product and Solutions
2.7.4 AngioDynamics Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 AngioDynamics Recent Developments and Future Plans
2.8 Hologic
2.8.1 Hologic Details
2.8.2 Hologic Major Business
2.8.3 Hologic Endoscope + Radiofrequency Ablation (RFA) Product and Solutions
2.8.4 Hologic Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Hologic Recent Developments and Future Plans
2.9 AtriCure
2.9.1 AtriCure Details
2.9.2 AtriCure Major Business
2.9.3 AtriCure Endoscope + Radiofrequency Ablation (RFA) Product and Solutions
2.9.4 AtriCure Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 AtriCure Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Endoscope + Radiofrequency Ablation (RFA) Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Endoscope + Radiofrequency Ablation (RFA) by Company Revenue
3.2.2 Top 3 Endoscope + Radiofrequency Ablation (RFA) Players Market Share in 2023
3.2.3 Top 6 Endoscope + Radiofrequency Ablation (RFA) Players Market Share in 2023
3.3 Endoscope + Radiofrequency Ablation (RFA) Market: Overall Company Footprint Analysis
3.3.1 Endoscope + Radiofrequency Ablation (RFA) Market: Region Footprint
3.3.2 Endoscope + Radiofrequency Ablation (RFA) Market: Company Product Type Footprint
3.3.3 Endoscope + Radiofrequency Ablation (RFA) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Endoscope + Radiofrequency Ablation (RFA) Consumption Value and Market Share by Type (2019-2024)
4.2 Global Endoscope + Radiofrequency Ablation (RFA) Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Endoscope + Radiofrequency Ablation (RFA) Consumption Value Market Share by Application (2019-2024)
5.2 Global Endoscope + Radiofrequency Ablation (RFA) Market Forecast by Application (2025-2030)
6 North America
6.1 North America Endoscope + Radiofrequency Ablation (RFA) Consumption Value by Type (2019-2030)
6.2 North America Endoscope + Radiofrequency Ablation (RFA) Consumption Value by Application (2019-2030)
6.3 North America Endoscope + Radiofrequency Ablation (RFA) Market Size by Country
6.3.1 North America Endoscope + Radiofrequency Ablation (RFA) Consumption Value by Country (2019-2030)
6.3.2 United States Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
6.3.3 Canada Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
6.3.4 Mexico Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Endoscope + Radiofrequency Ablation (RFA) Consumption Value by Type (2019-2030)
7.2 Europe Endoscope + Radiofrequency Ablation (RFA) Consumption Value by Application (2019-2030)
7.3 Europe Endoscope + Radiofrequency Ablation (RFA) Market Size by Country
7.3.1 Europe Endoscope + Radiofrequency Ablation (RFA) Consumption Value by Country (2019-2030)
7.3.2 Germany Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
7.3.3 France Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
7.3.5 Russia Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
7.3.6 Italy Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Market Size by Region
8.3.1 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Consumption Value by Region (2019-2030)
8.3.2 China Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
8.3.3 Japan Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
8.3.4 South Korea Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
8.3.5 India Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
8.3.7 Australia Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
9 South America
9.1 South America Endoscope + Radiofrequency Ablation (RFA) Consumption Value by Type (2019-2030)
9.2 South America Endoscope + Radiofrequency Ablation (RFA) Consumption Value by Application (2019-2030)
9.3 South America Endoscope + Radiofrequency Ablation (RFA) Market Size by Country
9.3.1 South America Endoscope + Radiofrequency Ablation (RFA) Consumption Value by Country (2019-2030)
9.3.2 Brazil Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
9.3.3 Argentina Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Endoscope + Radiofrequency Ablation (RFA) Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Endoscope + Radiofrequency Ablation (RFA) Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Endoscope + Radiofrequency Ablation (RFA) Market Size by Country
10.3.1 Middle East & Africa Endoscope + Radiofrequency Ablation (RFA) Consumption Value by Country (2019-2030)
10.3.2 Turkey Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
10.3.4 UAE Endoscope + Radiofrequency Ablation (RFA) Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Endoscope + Radiofrequency Ablation (RFA) Market Drivers
11.2 Endoscope + Radiofrequency Ablation (RFA) Market Restraints
11.3 Endoscope + Radiofrequency Ablation (RFA) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Endoscope + Radiofrequency Ablation (RFA) Industry Chain
12.2 Endoscope + Radiofrequency Ablation (RFA) Upstream Analysis
12.3 Endoscope + Radiofrequency Ablation (RFA) Midstream Analysis
12.4 Endoscope + Radiofrequency Ablation (RFA) Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Boston Scientific Corporation Conmed Corporation
Medtronic Plc (Covidien Plc)
Smith and Nephew Plc
Stryker Corporation
Halyard Health
Abbott Laboratories (St. Jude Medical, Inc.)
AngioDynamics
Hologic
AtriCure
听
听
*If Applicable.
